Search Results 1971-1980 of 2943 for 必应搜索引擎留痕咨询邮箱:lgooxc@hotmail.com
About this study. This randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, ...
About this study. The safety and effectiveness of TheraSphere will be evaluated in patients with unresectable hepatocellular carcinoma in whom treatment ...
In this study, participants with previously-treated locally-advanced unresectable or metastatic mismatched repair (MMR) deficient or microsatellite instability ...
After completion of PK studies during the first 2 treatment cycles, subjects will continue to receive treatment with ASTX727 from Cycle 3 onward (in 28-day ...
About this study. This study hypothesises that physical exercise in children with epilepsy will be associated with a significant reduction in interictal ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mocetinostat is an orally administered histone deacetylase (HDAC) inhibitor. Azacitidine is a hypomethylating agent (HMA) used to treat MDS. In this study, ...
About this study. The objective of this project is to refine and test a behavioral intervention to be administered in parallel with medical treatment in the ...
About this study. The purpose of this research study is to contribute to an existing registry that was developed by Virginia Commonwealth University (VCU).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.